Perugia, Italy – August 14, 2018.
Plasfer has closed an agreement with the University of Perugia to start a PhD programme. A PhD student will be selected for studies on the “Use of Platelets as Vectors of Therapeutic RNA for the Treatment of Gliobastoma Multiforme (GBM)”.
All informations and rules to participate to the selection can be found here.
Plasfer srls is a pre-clinical stage biopharmaceutical company, based in Umbria (Italy) specialized in the development of delivery of RNA-based drug through platelets using an innovative proprietary medical technology.
For further information, please contact: email@example.com